Trelegy Ellipta vs Advair Diskus
A side-by-side look at two respiratory medications advertised on TV. Informational only — not medical advice.
| US Trelegy Ellipta | US Advair Diskus | |
|---|---|---|
| Generic name | fluticasone/umeclidinium/vilanterol | fluticasone/salmeterol |
| Drug class | Inhaled Corticosteroid + LAMA + LABA | Inhaled Corticosteroid / LABA Combination |
| Treats | COPD, asthma | Asthma and COPD |
| Category | Respiratory | Respiratory |
| Manufacturer | GSK | GSK |
| Year approved | 2017 | 2000 |
| FDA warning | No boxed warning | Moderate warnings |
| Est. TV ad spend | $200M | — |
| Common side effects | Thrush, Respiratory infections, Headache, Cough | Thrush (mouth infection), Hoarse voice, Headache, Throat irritation |
Trelegy Ellipta
Advair Diskus
Frequently asked questions
Is Trelegy Ellipta or Advair Diskus better?
Neither is universally "better." Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) and Advair Diskus (fluticasone/salmeterol) are both used for respiratory, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Trelegy Ellipta and Advair Diskus?
Trelegy Ellipta is a Inhaled Corticosteroid + LAMA + LABA made by GSK, while Advair Diskus is a Inhaled Corticosteroid / LABA Combination made by GSK. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Trelegy Ellipta has the larger estimated TV advertising budget of the two.